From the FDA Drug Label
Sulfamethoxazole and trimethoprim injection must be given by intravenous infusion over a period of 60 to 90 minutes. Rapid infusion or bolus injection must be avoided.
The recommended rate of administration of intravenous (IV) Bactrim (trimethoprim/sulfamethoxazole) is by infusion over a period of 60 to 90 minutes. It is essential to avoid rapid infusion or bolus injection. 1 1
From the Research
Intravenous Bactrim (trimethoprim-sulfamethoxazole) should be administered at a rate not exceeding 10 mL per hour (for the diluted solution) over 60-90 minutes. For adult patients, the standard dose is typically 8-10 mg/kg/day of the trimethoprim component, divided into 2-4 equal doses. The medication should be diluted in 5% dextrose in water (D5W) prior to administration, with each 5 mL of concentrate diluted in 75-125 mL of D5W. This slow infusion rate is important to minimize adverse reactions such as hypotension, nausea, or vomiting that can occur with rapid administration. Patients should be monitored during infusion for signs of allergic reactions, particularly during the first infusion. Adequate hydration should be maintained throughout treatment to prevent crystalluria and kidney injury. The solution should appear clear; if precipitation or cloudiness is visible, the solution should be discarded. For patients with renal impairment, dose adjustment is necessary, with frequency reduction recommended for those with creatinine clearance below 30 mL/min, as supported by studies such as 2 which highlights the importance of adjusting doses in patients undergoing continuous venovenous hemodiafiltration. Additionally, monitoring for hyponatremia is crucial, especially in patients receiving high-dose trimethoprim-sulfamethoxazole, as noted in 3. It is also important to be aware of the potential for acute kidney injury associated with trimethoprim/sulfamethoxazole, as discussed in 4, and to monitor patients closely for signs of renal impairment.
Key Considerations
- Dose adjustment for renal impairment
- Monitoring for allergic reactions and signs of kidney injury
- Maintenance of adequate hydration
- Awareness of potential for hyponatremia and acute kidney injury
- Importance of slow infusion rate to minimize adverse reactions
Administration Guidelines
- Dilute in 5% dextrose in water (D5W) prior to administration
- Administer at a rate not exceeding 10 mL per hour over 60-90 minutes
- Monitor patients closely during infusion and throughout treatment
- Adjust dose and frequency as necessary based on patient's renal function and response to treatment, as informed by studies like 5, 6.